David Grant United States Air Force Medical Center Specialty Care Travel Reimbursement Demonstration Project, 10608-10610 [2013-03414]
Download as PDF
10608
Federal Register / Vol. 78, No. 31 / Thursday, February 14, 2013 / Notices
CONSUMER PRODUCT SAFETY
COMMISSION
DEPARTMENT OF DEFENSE
Office of the Secretary
Sunshine Act Meetings, Cancellation
U.S. Consumer Product Safety
Commission
AGENCY:
FEDERAL REGISTER CITATION OF PREVIOUS
ANNOUNCEMENT: Vol. 78, No. 27, Friday,
February 8, 2013, page 9387.
ANNOUNCED TIME AND DATE OF MEETING:
Wednesday, February 13, 2013, 10 a.m.–
11 a.m.
For a recorded
message containing the latest agenda
information, call (301) 504–7948.
MEETING CANCELED.
CONTACT PERSON FOR ADDITIONAL
INFORMATION: Todd A. Stevenson,
Office
of the Secretary, 4330 East West
Highway, Bethesda, MD 20814 (301)
504–7923.
Dated: February 12, 2013.
Todd A. Stevenson,
Secretary.
[FR Doc. 2013–03560 Filed 2–12–13; 4:15 pm]
BILLING CODE 6355–01–P
CONSUMER PRODUCT SAFETY
COMMISSION
Sunshine Act Meeting Notice
Wednesday, February 20,
2013, 10:00 a.m.–11:00 a.m.
TIME AND DATE:
Room 420, Bethesda Towers,
4330 East West Highway, Bethesda,
Maryland.
PLACE:
Commission Meeting—Open to
the Public.
STATUS:
Matters To Be Considered
Decisional Matter: Sections 1112/1118
Requirements for Third Party
Conformity Assessment Bodies—Draft
Final.
A live webcast of the Meeting can be
viewed at www.cpsc.gov/webcast.
For a recorded message containing the
latest agenda information, call (301)
504–7948.
sroberts on DSK5SPTVN1PROD with NOTICES
CONTACT PERSON FOR MORE INFORMATION:
Todd A. Stevenson, Office of the
Secretary, U.S. Consumer Product
Safety Commission, 4330 East West
Highway, Bethesda, MD 20814, (301)
504–7923.
Dated: February 12, 2013.
Todd A. Stevenson,
Secretary.
[FR Doc. 2013–03561 Filed 2–12–13; 4:15 pm]
BILLING CODE 6355–01–P
VerDate Mar<15>2010
17:16 Feb 13, 2013
Jkt 229001
David Grant United States Air Force
Medical Center Specialty Care Travel
Reimbursement Demonstration Project
Department of Defense.
Notice of demonstration project.
AGENCY:
ACTION:
This notice is to advise
interested parties of a Military Health
System (MHS) demonstration project
under the authority of Title 10, United
States Code, Section 1092, entitled
David Grant United States Air Force
Medical Center Specialty Care Travel
Reimbursement Demonstration Project.
This demonstration project is intended
to test whether providing travel
reimbursement will increase utilization
of the direct care system by selected
beneficiaries. The Military Treatment
Facility (MTF) commander would
determine based on the MTF’s
individual capabilities, which specialty
services in the facility currently have
excess capacity and then offer those
specialty services to qualified
beneficiaries, including TRICARE
Prime, TRICARE Standard and
TRICARE for Life (TFL) beneficiaries,
who reside more than one hour drive
time away from the David Grant United
States Air Force Medical Center
(DGMC). These beneficiaries would be
enticed to receive this specialty care
from the more distant MTF rather than
a closer authorized provider through the
payment of travel costs from their
residence to the MTF. The travel
reimbursement offered under this
demonstration will include roundtrip
mileage reimbursement from the
patient’s residence to DGMC.
Reimbursement may also include
overnight lodging for the patient the
evening before an early morning
procedure and travel for a non-medical
attendant for patients when medically
indicated. This demonstration will test
if the travel reimbursement incentive
can produce a cost of care savings
related to the recapturing of selected
DoD beneficiaries. This travel benefit
will be authorized only when the MTF
commander (or designee) determines
that the DoD cost of funding the care
(including the travel benefit) in the MTF
is likely to be less than the DoD cost to
provide the care in the purchased care
system. This demonstration also seeks
to maximize the utilization of DGMC
specialists, maintain an adequate
clinical case mix of patients for
approved Graduate Medical Education
program functioning in the MTF, and
sustain readiness-related medical skills
SUMMARY:
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
activities for the military providers. This
demonstration would be initially
conducted at DGMC and its satellite
clinic, the McClellan Clinic (MCC) as
well as the clinic located at Beale Air
Force Base (Beale). However, it could be
expanded to other MTFs with the
approval of the Assistant Secretary of
Defense (Health Affairs), and a
subsequent Federal Register
notification.
DATES: This demonstration will be
effective 60 days from the date of this
notice for a period of thirty six (36)
months, unless extended by a separate
action.
ADDRESSES: TRICARE Management
Activity (TMA), Health Plan Operations,
7700 Arlington Boulevard, Suite 5101,
Falls Church, VA 22042–5101.
FOR FURTHER INFORMATION CONTACT: For
questions pertaining to this
demonstration project, please contact
Maj. Kevin Schultz at (707) 423–7887.
SUPPLEMENTARY INFORMATION:
a. Background
A basic principle of the TRICARE
program and the Military Health System
(MHS) business design is that MTFs
have first priority for providing referred
specialty care or inpatient care for all
TRICARE Prime enrollees. If the MTF
does not have the capability to provide
the needed care or cannot provide the
care within the required access
standard, then the care will be referred
to the TRICARE provider network.
TRICARE Prime access standards
require referrals for specialty care
services to be provided with an
appropriately trained provider within 4
weeks or sooner, if required, and within
1-hour travel time from the beneficiary’s
residence. The geographic area that
represents 1-hour travel time
surrounding an MTF is referred to as the
Right of First Refusal (ROFR) area.
For those Prime beneficiaries that live
outside the ROFR area, their specialty
care is referred to the civilian network.
TRICARE Standard and TFL
beneficiaries maintain freedom of
choice and may receive specialty care
from any TRICARE authorized civilian
provider or alternatively may elect to
receive their care in a MTF to the extent
such care is available to them.
DoD’s authority to reimburse travel
expenses for TRICARE beneficiaries is
currently limited to the TRICARE Prime
Travel Benefit, provided pursuant to 10
USC 1074i, which reimburses only
Prime beneficiaries for non-emergent
medically necessary specialty care that
is provided more than 100 miles from
the beneficiary’s primary care provider’s
office to the nearest specialist’s office.
E:\FR\FM\14FEN1.SGM
14FEN1
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 31 / Thursday, February 14, 2013 / Notices
The benefit is limited to specialty
referrals when no other options for care
are available within 100 miles of the
primary care provider. This
demonstration project is designed to test
the effectiveness of a voluntary local
travel reimbursement designed to
recapture certain specialty care within
the direct care system for beneficiaries
who reside outside of the ROFR area.
David Grant United States Air Force
Medical Center (DGMC) at Travis Air
Force Base (AFB) is currently a 116-bed
facility and fulfills a key role in the Air
Force Medical Service as the second
largest deployment platform. A robust
TRICARE eligible population remains in
the Northern California area, however
much of it is located just beyond a 60minute drive time from DGMC. DGMC
also operates the McClellan satellite
clinic (MCC) in Sacramento. This
satellite clinic offers an opportunity to
recapture a larger DoD beneficiary
population than is available in the
existing DGMC Prime Service Area and
ROFR area for specialty care. Based on
surveys of existing patients at the clinic,
travel distance is the most significant
factor for why patients do not utilize
DGMC for specialty care that may only
be available at the MTF vice the clinic.
Over the last year, DGMC specialties
have begun offering outpatient services
at MCC, with appointment availability
varying based on patient demand. The
majority of patient care can be provided
at MCC including initial consults,
medication management, and pre/postoperative visits. When required, the
physician will schedule a patient for
surgery or other procedure not available
at MCC, at DGMC. The feedback from
patients has been very positive as MCC
offers specialty services much closer to
the patient’s residence.
These DGMC efforts have proven to be
very successful in recapturing specialty
care in the immediate area surrounding
the hospital. Through this
demonstration project, DGMC will now
seek to reach the larger beneficiary
population that resides beyond the 60
minute drive time to the MTF (those
outside the ROFR area) to maximize the
direct care system and improve provider
currency and deployment capability
through increased patient acuity and
volume.
Under this demonstration, DGMC
would reimburse TRICARE Prime,
TRICARE Standard, and TFL
beneficiaries who live outside of the
ROFR area of DGMC for reasonable
travel expenses when they agree to
receive specialty procedures, including
diagnostic and surgical procedures not
otherwise available at MCC or Beale
AFB, in specialties determined by the
VerDate Mar<15>2010
17:16 Feb 13, 2013
Jkt 229001
Commander of DGMC to have excess
capacity. Reimbursement will only be
authorized when the beneficiary resides
outside of the ROFR area of the DGMC
and (1) a specialty provider at MCC or
Beale sends a patient to DGMC for care
not available at MCC or (2) a patient is
assessed by a specialist who is an
authorized TRICARE provider and
identified as a candidate for a surgical
intervention to be performed at DGMC.
There will be no requirement for a
network provider outside of the ROFR
area to refer the patient to DGMC, but
all authorized specialty providers will
be given information on how to make
the referral if the patient desires to use
DGMC. The demonstration project will
be communicated to the non-Prime
beneficiaries through multiple
communications channels, to include
provider outreach and other media.
For purposes of this demonstration,
once the beneficiary is identified as
requiring a procedure at DGMC, they
will be referred to the Beneficiary
Counseling and Assistance Coordinator
(BCAC) at MCC. The BCAC will review
the patient information and determine if
the patient is eligible for travel
reimbursement. If so, the BCAC will
brief the patient as to the process and
assist the patient in applying for the
travel as well as processing any travel
vouchers. Travel for a non-medical
attendant (NMA) for patients who
require admission may be authorized
when the attendance of a NMA is
medically indicated. When the patient’s
procedure is to occur before 8:00 a.m.,
then reimbursement for the patient and
an NMA may be authorized for lodging
for the one night prior to the procedure.
The maximum reimbursement shall be
the lesser of the actual lodging costs or
the locality lodging rate. This shall be in
addition to the normal mileage
reimbursement of 51 cents per mile. If
the beneficiary is hospitalized
overnight, the NMA may also be
authorized reimbursement for the
mileage back to their residence. The
MCC BCAC will assist with making
arrangements at the Travis Fisher
House, base lodging, or local hotel,
based on availability. The amount of
travel to DGMC will be minimized as
much as possible by offering pre/postoperative visits at MCC, as well as
diagnostic testing either at MCC or in
the civilian network.
Beneficiary participation in this
demonstration program is strictly
voluntary; beneficiaries will be allowed
to seek specialty procedures/care in the
private care system if they prefer. The
60 minute drive time access to care
standard for Prime beneficiaries would
still be applicable, so Prime
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
10609
beneficiaries wanting to participate
would have to waive their access to care
standards. The authorization and
oversight of the reimbursement and, if
needed, the coordination with other
healthcare insurance (OHI) plans will be
the responsibility of the MTF.
b. Implementation
This demonstration will be effective
60 days from the date of this notice for
a period of thirty six (36) months.
c. Evaluation
The results of this demonstration will
allow a focused study on the impact a
voluntary local travel reimbursement
will have on encouraging TRICARE
beneficiaries who live beyond a 60
minute drive time to an MTF (those
outside the ROFR area) to nonetheless
utilize the direct care system for needed
specialty care in lieu of electing a closer,
purchased care provider. Throughout
the demonstration project, there will be
monthly tracking of the number of
DGMC inpatient admissions and
outpatient encounters by demonstration
participants who reside outside the
DGMC ROFR area for the identified
specialties. There will also be quarterly
tracking of marketing initiatives to
measure their effectiveness in ensuring
that eligible beneficiaries in the target
area are aware of the availability of
specialty services at MCC and the
corresponding travel reimbursement to/
from DGMC. Success of the
demonstration would be determined in
part by a substantial increase in
encounters from beneficiaries that
reside outside the DGMC ROFR area for
identified specialties while at the same
time there is no increase in the referral
rate to the network from DGMC for these
same specialties for TRICARE Prime
beneficiaries that reside within the
ROFR area. Data will also be gathered
regarding local travel reimbursement
expenditures and the estimated
purchased care cost-savings of
demonstration participants. At the end
of the demonstration, a thorough
business case analysis will be
conducted of the relevant expenditures
and cost-savings, in addition to an
assessment of the demonstration
project’s impact on MTF productivity,
provider currency in the identified
specialties, and utilization of excess
capacity in the direct care system.
Following this evaluation, Health
Affairs may seek permanent authority to
implement a travel reimbursement
program for certain beneficiaries when
they agree to receive specialty care in
the direct care system.
E:\FR\FM\14FEN1.SGM
14FEN1
10610
Federal Register / Vol. 78, No. 31 / Thursday, February 14, 2013 / Notices
Dated: February 1, 2013.
Patricia L. Toppings,
OSD Federal Register Liaison Officer,
Department of Defense.
[FR Doc. 2013–03414 Filed 2–13–13; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Defense Acquisition Regulations
System
Waiver for Certain Defense Items
Produced in the United Kingdom
Defense Acquisition
Regulations System, Department of
Defense (DoD).
ACTION: Notice.
AGENCY:
The Under Secretary of
Defense (Acquisition, Technology, and
Logistics) is waiving the statutory
limitation of 10 U.S.C. 2534 for certain
defense items produced in the United
Kingdom (UK). The law limits DoD
procurement of certain items to sources
in the national technology and
industrial base. The waiver will permit
procurement of enumerated items from
sources in the UK, unless otherwise
restricted by statute.
DATES: This waiver is effective
beginning March 1, 2013 until February
28, 2014.
FOR FURTHER INFORMATION CONTACT: Ms.
Patricia Foley, OUSD (AT&L) Director,
Office of the Defense Procurement and
Acquisition Policy, Contract Policy and
International Contracting, Room 5E621,
3060 Defense Pentagon, Washington, DC
20301–3060, telephone (703) 693–1145.
SUPPLEMENTARY INFORMATION:
Subsection (a) of 10 U.S.C. 2534
provides that the Secretary of Defense
may procure the items listed in that
subsection only if the manufacturer of
the item is part of the national
technology and industrial base.
Subsection (i) of 10 U.S.C. 2534
authorizes the Secretary of Defense to
exercise the waiver authority in
subsection (d), on the basis of the
applicability of paragraph (2) or (3) of
that subsection, only if the waiver is
made for a particular item listed in
subsection (a) and for a particular
foreign country. Subsection (d)
authorizes a waiver if the Secretary
determines that application of the
limitation ‘‘would impede the reciprocal
procurement of defense items under a
memorandum of understanding
providing for reciprocal procurement of
defense items’’ and if he determines that
‘‘that country does not discriminate
against defense items produced in the
United States to a greater degree than
sroberts on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:16 Feb 13, 2013
Jkt 229001
the United States discriminates against
defense items produced in that
country.’’ The Secretary of Defense has
delegated the waiver authority of 10
U.S.C. 2534(d) to the Under Secretary of
Defense (Acquisition, Technology, and
Logistics).
DoD has had a Reciprocal Defense
Procurement Memorandum of
Understanding (MOU) with the UK
since 1975, most recently renewed on
December 16, 2004.
The Under Secretary of Defense
(Acquisition, Technology, and Logistics)
finds that the UK does not discriminate
against defense items produced in the
United States to a greater degree than
the United States discriminates against
defense items produced in the UK, and
also finds that application of the
limitation in 10 U.S.C. 2534 against
defense items produced in the UK
would impede the reciprocal
procurement of defense items under the
MOU.
Under the authority of 10 U.S.C. 2534,
the Under Secretary of Defense
(Acquisition, Technology, and Logistics)
has determined that application of the
limitation of 10 U.S.C. 2534(a) to the
procurement of any defense item
produced in the UK that is listed below
would impede the reciprocal
procurement of defense items under the
MOU with the UK.
On the basis of the foregoing, the
Under Secretary of Defense
(Acquisition, Technology, and Logistics)
is waiving the limitation in 10 U.S.C.
2534(a) for procurements of any defense
item listed below that is produced in the
UK. This waiver applies only to the
limitations in 10 U.S.C. 2534(a). This
waiver applies to procurements under
solicitations issued during the period
from March 1, 2013 to February 28,
2014. Similar waivers have been granted
since 1998, most recently in 2012 (77 FR
2278, January 17, 2012).
List of Items to Which This Waiver
Applies
1. Air circuit breakers.
2. Gyrocompasses.
3. Electronic navigation chart systems.
4. Steering controls.
5. Pumps.
6. Propulsion and machinery control
systems.
7. Totally enclosed lifeboats.
Manuel Quinones,
Editor, Defense Acquisition Regulations
System.
[FR Doc. 2013–03474 Filed 2–13–13; 8:45 am]
BILLING CODE 5001–06–P
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
DEPARTMENT OF DEFENSE
Office of the Secretary
TRICARE; Demonstration Project for
Participation in Maryland Multi-Payer
Patient Centered Medical Home
Program (MMPCMHP) Demonstration
Department of Defense (DoD).
Notice of Demonstration Project.
AGENCY:
ACTION:
This notice advises interested
parties of a Military Health System
(MHS) Demonstration project under the
authority of Title 10, United States
Code, Section 1092, entitled Department
of Defense (DoD) Enhanced Access to
Patient Centered Medical Home
(PCMH): Participation in Maryland
Multi-payer Patient Centered Medical
Home Program (MMPCMHP).
DATES: The demonstration program will
be effective 30 days after publication in
the Federal Register and have a two
year duration.
ADDRESSES: TRICARE Management
Activity (TMA), TRICARE Regional
Office North, 1700 North Moore Street,
Suite 1200, Arlington, VA 22209.
FOR FURTHER INFORMATION CONTACT:
Capt. John O’Boyle, TMA, TRICARE
Regional Office—North, telephone (703)
588–1831.
SUPPLEMENTARY INFORMATION: The MHS
has adopted the PCMH concept as the
strategy of choice for the direct care
system and is now using this
demonstration to evaluate and provide a
PCMH model in the purchased care
portion of the TRICARE program.
The MHS defines PCMH as a model
of care adopted by the American
Academy of Family Physicians, the
American Academy of Pediatrics, the
American College of Physicians, and the
American Osteopathic Association that
seeks to strengthen the provider-patient
relationship by replacing episodic care
with coordinated care and a long-term
healing relationship. In PCMH practices,
each patient has an ongoing relationship
with a personal provider who leads a
team that takes collective responsibility
for patient care. The provider-led care
team is responsible for providing all the
patient’s health care needs and, when
required, arranging for appropriate care
with other qualified providers.
A particular challenge in
implementing the PCMH concept in the
purchased care portion of the TRICARE
program has been the inability to
distinguish and employ reimbursement
methodologies which encourage
network providers to accept TRICARE
beneficiaries under a Medical Home
model. Current contractual incentives
encourage network discounts which
SUMMARY:
E:\FR\FM\14FEN1.SGM
14FEN1
Agencies
[Federal Register Volume 78, Number 31 (Thursday, February 14, 2013)]
[Notices]
[Pages 10608-10610]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03414]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
David Grant United States Air Force Medical Center Specialty Care
Travel Reimbursement Demonstration Project
AGENCY: Department of Defense.
ACTION: Notice of demonstration project.
-----------------------------------------------------------------------
SUMMARY: This notice is to advise interested parties of a Military
Health System (MHS) demonstration project under the authority of Title
10, United States Code, Section 1092, entitled David Grant United
States Air Force Medical Center Specialty Care Travel Reimbursement
Demonstration Project. This demonstration project is intended to test
whether providing travel reimbursement will increase utilization of the
direct care system by selected beneficiaries. The Military Treatment
Facility (MTF) commander would determine based on the MTF's individual
capabilities, which specialty services in the facility currently have
excess capacity and then offer those specialty services to qualified
beneficiaries, including TRICARE Prime, TRICARE Standard and TRICARE
for Life (TFL) beneficiaries, who reside more than one hour drive time
away from the David Grant United States Air Force Medical Center
(DGMC). These beneficiaries would be enticed to receive this specialty
care from the more distant MTF rather than a closer authorized provider
through the payment of travel costs from their residence to the MTF.
The travel reimbursement offered under this demonstration will include
roundtrip mileage reimbursement from the patient's residence to DGMC.
Reimbursement may also include overnight lodging for the patient the
evening before an early morning procedure and travel for a non-medical
attendant for patients when medically indicated. This demonstration
will test if the travel reimbursement incentive can produce a cost of
care savings related to the recapturing of selected DoD beneficiaries.
This travel benefit will be authorized only when the MTF commander (or
designee) determines that the DoD cost of funding the care (including
the travel benefit) in the MTF is likely to be less than the DoD cost
to provide the care in the purchased care system. This demonstration
also seeks to maximize the utilization of DGMC specialists, maintain an
adequate clinical case mix of patients for approved Graduate Medical
Education program functioning in the MTF, and sustain readiness-related
medical skills activities for the military providers. This
demonstration would be initially conducted at DGMC and its satellite
clinic, the McClellan Clinic (MCC) as well as the clinic located at
Beale Air Force Base (Beale). However, it could be expanded to other
MTFs with the approval of the Assistant Secretary of Defense (Health
Affairs), and a subsequent Federal Register notification.
DATES: This demonstration will be effective 60 days from the date of
this notice for a period of thirty six (36) months, unless extended by
a separate action.
ADDRESSES: TRICARE Management Activity (TMA), Health Plan Operations,
7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042-5101.
FOR FURTHER INFORMATION CONTACT: For questions pertaining to this
demonstration project, please contact Maj. Kevin Schultz at (707) 423-
7887.
SUPPLEMENTARY INFORMATION:
a. Background
A basic principle of the TRICARE program and the Military Health
System (MHS) business design is that MTFs have first priority for
providing referred specialty care or inpatient care for all TRICARE
Prime enrollees. If the MTF does not have the capability to provide the
needed care or cannot provide the care within the required access
standard, then the care will be referred to the TRICARE provider
network. TRICARE Prime access standards require referrals for specialty
care services to be provided with an appropriately trained provider
within 4 weeks or sooner, if required, and within 1-hour travel time
from the beneficiary's residence. The geographic area that represents
1-hour travel time surrounding an MTF is referred to as the Right of
First Refusal (ROFR) area.
For those Prime beneficiaries that live outside the ROFR area,
their specialty care is referred to the civilian network. TRICARE
Standard and TFL beneficiaries maintain freedom of choice and may
receive specialty care from any TRICARE authorized civilian provider or
alternatively may elect to receive their care in a MTF to the extent
such care is available to them.
DoD's authority to reimburse travel expenses for TRICARE
beneficiaries is currently limited to the TRICARE Prime Travel Benefit,
provided pursuant to 10 USC 1074i, which reimburses only Prime
beneficiaries for non-emergent medically necessary specialty care that
is provided more than 100 miles from the beneficiary's primary care
provider's office to the nearest specialist's office.
[[Page 10609]]
The benefit is limited to specialty referrals when no other options for
care are available within 100 miles of the primary care provider. This
demonstration project is designed to test the effectiveness of a
voluntary local travel reimbursement designed to recapture certain
specialty care within the direct care system for beneficiaries who
reside outside of the ROFR area.
David Grant United States Air Force Medical Center (DGMC) at Travis
Air Force Base (AFB) is currently a 116-bed facility and fulfills a key
role in the Air Force Medical Service as the second largest deployment
platform. A robust TRICARE eligible population remains in the Northern
California area, however much of it is located just beyond a 60-minute
drive time from DGMC. DGMC also operates the McClellan satellite clinic
(MCC) in Sacramento. This satellite clinic offers an opportunity to
recapture a larger DoD beneficiary population than is available in the
existing DGMC Prime Service Area and ROFR area for specialty care.
Based on surveys of existing patients at the clinic, travel distance is
the most significant factor for why patients do not utilize DGMC for
specialty care that may only be available at the MTF vice the clinic.
Over the last year, DGMC specialties have begun offering outpatient
services at MCC, with appointment availability varying based on patient
demand. The majority of patient care can be provided at MCC including
initial consults, medication management, and pre/post-operative visits.
When required, the physician will schedule a patient for surgery or
other procedure not available at MCC, at DGMC. The feedback from
patients has been very positive as MCC offers specialty services much
closer to the patient's residence.
These DGMC efforts have proven to be very successful in recapturing
specialty care in the immediate area surrounding the hospital. Through
this demonstration project, DGMC will now seek to reach the larger
beneficiary population that resides beyond the 60 minute drive time to
the MTF (those outside the ROFR area) to maximize the direct care
system and improve provider currency and deployment capability through
increased patient acuity and volume.
Under this demonstration, DGMC would reimburse TRICARE Prime,
TRICARE Standard, and TFL beneficiaries who live outside of the ROFR
area of DGMC for reasonable travel expenses when they agree to receive
specialty procedures, including diagnostic and surgical procedures not
otherwise available at MCC or Beale AFB, in specialties determined by
the Commander of DGMC to have excess capacity. Reimbursement will only
be authorized when the beneficiary resides outside of the ROFR area of
the DGMC and (1) a specialty provider at MCC or Beale sends a patient
to DGMC for care not available at MCC or (2) a patient is assessed by a
specialist who is an authorized TRICARE provider and identified as a
candidate for a surgical intervention to be performed at DGMC. There
will be no requirement for a network provider outside of the ROFR area
to refer the patient to DGMC, but all authorized specialty providers
will be given information on how to make the referral if the patient
desires to use DGMC. The demonstration project will be communicated to
the non-Prime beneficiaries through multiple communications channels,
to include provider outreach and other media.
For purposes of this demonstration, once the beneficiary is
identified as requiring a procedure at DGMC, they will be referred to
the Beneficiary Counseling and Assistance Coordinator (BCAC) at MCC.
The BCAC will review the patient information and determine if the
patient is eligible for travel reimbursement. If so, the BCAC will
brief the patient as to the process and assist the patient in applying
for the travel as well as processing any travel vouchers. Travel for a
non-medical attendant (NMA) for patients who require admission may be
authorized when the attendance of a NMA is medically indicated. When
the patient's procedure is to occur before 8:00 a.m., then
reimbursement for the patient and an NMA may be authorized for lodging
for the one night prior to the procedure. The maximum reimbursement
shall be the lesser of the actual lodging costs or the locality lodging
rate. This shall be in addition to the normal mileage reimbursement of
51 cents per mile. If the beneficiary is hospitalized overnight, the
NMA may also be authorized reimbursement for the mileage back to their
residence. The MCC BCAC will assist with making arrangements at the
Travis Fisher House, base lodging, or local hotel, based on
availability. The amount of travel to DGMC will be minimized as much as
possible by offering pre/post-operative visits at MCC, as well as
diagnostic testing either at MCC or in the civilian network.
Beneficiary participation in this demonstration program is strictly
voluntary; beneficiaries will be allowed to seek specialty procedures/
care in the private care system if they prefer. The 60 minute drive
time access to care standard for Prime beneficiaries would still be
applicable, so Prime beneficiaries wanting to participate would have to
waive their access to care standards. The authorization and oversight
of the reimbursement and, if needed, the coordination with other
healthcare insurance (OHI) plans will be the responsibility of the MTF.
b. Implementation
This demonstration will be effective 60 days from the date of this
notice for a period of thirty six (36) months.
c. Evaluation
The results of this demonstration will allow a focused study on the
impact a voluntary local travel reimbursement will have on encouraging
TRICARE beneficiaries who live beyond a 60 minute drive time to an MTF
(those outside the ROFR area) to nonetheless utilize the direct care
system for needed specialty care in lieu of electing a closer,
purchased care provider. Throughout the demonstration project, there
will be monthly tracking of the number of DGMC inpatient admissions and
outpatient encounters by demonstration participants who reside outside
the DGMC ROFR area for the identified specialties. There will also be
quarterly tracking of marketing initiatives to measure their
effectiveness in ensuring that eligible beneficiaries in the target
area are aware of the availability of specialty services at MCC and the
corresponding travel reimbursement to/from DGMC. Success of the
demonstration would be determined in part by a substantial increase in
encounters from beneficiaries that reside outside the DGMC ROFR area
for identified specialties while at the same time there is no increase
in the referral rate to the network from DGMC for these same
specialties for TRICARE Prime beneficiaries that reside within the ROFR
area. Data will also be gathered regarding local travel reimbursement
expenditures and the estimated purchased care cost-savings of
demonstration participants. At the end of the demonstration, a thorough
business case analysis will be conducted of the relevant expenditures
and cost-savings, in addition to an assessment of the demonstration
project's impact on MTF productivity, provider currency in the
identified specialties, and utilization of excess capacity in the
direct care system. Following this evaluation, Health Affairs may seek
permanent authority to implement a travel reimbursement program for
certain beneficiaries when they agree to receive specialty care in the
direct care system.
[[Page 10610]]
Dated: February 1, 2013.
Patricia L. Toppings,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2013-03414 Filed 2-13-13; 8:45 am]
BILLING CODE 5001-06-P